Profound Medical Corp. 8-K

What Happened Profound Medical Corp. (PROF) filed a Form 8-K on May 14, 2026, disclosing that its TULSA Procedure™ will be highlighted in four oral presentations at the American Urological Association (AUA) Annual Meeting in Washington, DC on May 16, 2026. The company furnished a press release dated May 14, 2026 as Exhibit 99.1. The report was signed by CFO Rashed Dewan.

Key Details

• Filing date: May 14, 2026 (Form 8-K, Regulation FD disclosure).
• Event: Four oral presentations featuring the TULSA Procedure at the AUA Annual Meeting on May 16, 2026, in Washington, DC.
• Press release: Issued May 14, 2026 and furnished as Exhibit 99.1 to the 8-K.
• Signature: Report signed by Rashed Dewan, Chief Financial Officer.

Why It Matters This 8-K informs investors that Profound is obtaining clinical and professional visibility for its TULSA Procedure at a major urology conference, which can support awareness among clinicians and potential hospital customers. Because the filing is a Regulation FD disclosure, it ensures the company publicly shared this event information rather than releasing it selectively. Investors should note the timing (May 16, 2026) for any subsequent company updates, clinical data releases, or commercial announcements tied to the presentations.